A phase I trial and pharmacokinetic (PK) study of vorinostat (SAHA) in combination with 13 cis-retinoic acid (13cRA) in children with refractory neuroblastomas, medulloblastomas, primitive neuroectodermal tumors (PNETs), and atypical teratoid rhabdoid tumor
暂无分享,去创建一个
R. Gilbertson | P. Adamson | M. Ames | C. Stewart | M. Fouladi | Julie R. Park | S. Blaney | J. Zwiebel | A. Ingle | Junfeng Sun